index - Équipe Biomarqueurs Radiopharmaceutiques et Neurochimiques

Derniers dépôts

Documents en texte intégral

81

Notices

91

 

Mots clés

Drug discovery Striatum Analytical confounders Brain 18FFluorodeoxyglucose Amyloid-β plaques Biomarqueurs Multiple sclerosis 18F-florbetapir FMRI Neurodegenerative diseases Dementia Frontotemporal lobar degeneration PET/MRI 18FFDG Pharmaco-fUS 11CPF-3274167 3D virtual histopathology Α2-adrenergic receptors Alzheimer Diagnosis Radiopharmaceutical Remote memory Neuroimaging 18 FF13640 Analytical Chemistry Choroid plexus Alzheimer's disease Radiotracer A-BETA 5-HT 6 receptor 5-Ht1A and 5-HT6 receptors Stroke Accident vasculaire cérébral Sniffing Cerebrospinal fluid Inflammation 5-HT1A Creutzfeldt-Jakob disease Neuroinflammation Noradrenaline TEP Proteinopathies Animal models Central nervous system Neuropharmacology MicroPET 18FFDG micro PET Parkinson's disease Synucleinopathies Psychiatry Agonists 14-3-3 protein LCS Alert system Agonistes AMAN syndrome Acute ischemic stroke Recent memory PET imaging 5-HT 1A receptors Locus coeruleus Alzheimer diagnosis Multiple system atrophy Maladies neurodégénératives Olfaction Adverse events 18 F2FNQ1P Agonist Rat 11CR-PK11195 Amyloid Amyloid-beta peptides Alzheimer’s disease Alphasynucléine 5-HT1A receptors Positron emission tomography Animal model PET System-level consolidation Biomarkers Biomarker 11Cyohimbine Non-human primate Alpha-synuclein Anti-CD20 Magnetic resonance imaging Amyloid-beta Démence à corps de Lewy Serotonin Amyotrophic lateral sclerosis Maladie d'Alzheimer Piriform cortex Acute respiratory distress syndrome Acute inflammatory demyelinating polyneuropathy Magnetic resonance elastography Middle cerebral artery occlusion 5-HT6 receptor Amyloid‐β